Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

New pertussis vaccination approaches: en route to protect newborns?

Locht C, Mielcarek N.

FEMS Immunol Med Microbiol. 2012 Nov;66(2):121-33. doi: 10.1111/j.1574-695X.2012.00988.x. Epub 2012 Jun 13. Review.

2.

Do we need a new vaccine to control the re-emergence of pertussis?

Mills KH, Ross PJ, Allen AC, Wilk MM.

Trends Microbiol. 2014 Feb;22(2):49-52. doi: 10.1016/j.tim.2013.11.007.

PMID:
24485284
3.

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.

Witt MA, Katz PH, Witt DJ.

Clin Infect Dis. 2012 Jun;54(12):1730-5. doi: 10.1093/cid/cis287. Epub 2012 Mar 15.

4.

Whooping cough, twenty years from acellular vaccines introduction.

Greco D, Esposito S, Tozzi A, Pandolfi E, Icardi G, Giammanco A.

Ann Ig. 2015 Mar-Apr;27(2):415-31. doi: 10.7416/ai.2015.2029.

PMID:
26051141
5.

Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.

Thierry-Carstensen B, Dalby T, Stevner MA, Robbins JB, Schneerson R, Trollfors B.

Vaccine. 2013 Oct 25;31(45):5178-91. doi: 10.1016/j.vaccine.2013.08.034. Epub 2013 Aug 28. Review.

6.

Pertussis vaccine trials in the 1990s.

Lambert LC.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S4-9. doi: 10.1093/infdis/jit592. Review.

7.

The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.

Bettinger JA, Halperin SA, De Serres G, Scheifele DW, Tam T.

Pediatr Infect Dis J. 2007 Jan;26(1):31-5.

PMID:
17195702
8.

Which strategy for pertussis vaccination today?

Girard DZ.

Paediatr Drugs. 2002;4(5):299-313. Review.

PMID:
11994035
9.

[New vaccines against Bordetella Pertussis].

Eskola J, Mertsola J.

Duodecim. 1996;112(13):1137-8. Finnish. No abstract available.

PMID:
10596079
10.

Pertussis vaccination and whooping cough: and now what?

Guiso N.

Expert Rev Vaccines. 2014 Oct;13(10):1163-5. doi: 10.1586/14760584.2014.941816. Epub 2014 Jul 14.

PMID:
25020131
11.

Pertussis: persistent pathogen, imperfect vaccines.

Yeh SH.

Expert Rev Vaccines. 2003 Feb;2(1):113-27. Review.

PMID:
12901603
12.

Re-emergence of pertussis: what are the solutions?

Libster R, Edwards KM.

Expert Rev Vaccines. 2012 Nov;11(11):1331-46. doi: 10.1586/erv.12.118. Review. Erratum in: Expert Rev Vaccines. 2013 Feb;12(2):240-2.

PMID:
23249233
13.

[Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].

Campins M, Moreno-Pérez D, Gil-de Miguel A, González-Romo F, Moraga-Llop FA, Arístegui-Fernández J, Goncé-Mellgren A, Bayas JM, Salleras-Sanmartí L.

Enferm Infecc Microbiol Clin. 2013 Apr;31(4):240-53. doi: 10.1016/j.eimc.2012.12.011. Epub 2013 Feb 12. Review. Spanish.

PMID:
23411362
14.

Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

[No authors listed]

MMWR Recomm Rep. 1997 Mar 28;46(RR-7):1-25. Erratum in: MMWR Morb Mortal Wkly Rep 1997 Aug 1;46(30):706.

15.

[Pertussis vaccines: acellular versus whole cell. Perhaps a return to the past?].

Cofré J.

Rev Chilena Infectol. 2015 Oct;32(5):559-63. doi: 10.4067/S0716-10182015000600010. Spanish.

16.

Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.

Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB.

Pediatrics. 2001 Dec;108(6):E115. Review.

PMID:
11731642
17.

Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.

Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P.

Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Review.

PMID:
22709953
18.

Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses.

Sheridan SL, Ware RS, Grimwood K, Lambert SB.

Vaccine. 2015 Sep 22;33(39):5027-30. doi: 10.1016/j.vaccine.2015.08.021. Epub 2015 Aug 19.

PMID:
26297874
19.

[Pertussis vaccine for adolescents and adults].

Perret P C.

Rev Chilena Infectol. 2006 Sep;23(3):257-60. Epub 2006 Aug 4. Spanish.

20.

Is there a need for a new generation of vaccines against pertussis?

Storsaeter J, Wolter J.

Expert Opin Emerg Drugs. 2006 May;11(2):195-205. Review.

PMID:
16634696
Items per page

Supplemental Content

Write to the Help Desk